These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20957014)

  • 1. [Synthesis of G3.5 dendrimer-2-aminoethyl ß-D-galactopyranoside conjugates and its specificity on hepatocyte targeting in vitro].
    Zhang M; Wang J; Li YJ; Wang XT; Hu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):554-8. PubMed ID: 20957014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.
    Liu J; Liu J; Chu L; Wang Y; Duan Y; Feng L; Yang C; Wang L; Kong D
    Int J Nanomedicine; 2010 Dec; 6():59-69. PubMed ID: 21289982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
    Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
    Iacobazzi RM; Porcelli L; Lopedota AA; Laquintana V; Lopalco A; Cutrignelli A; Altamura E; Di Fonte R; Azzariti A; Franco M; Denora N
    Int J Pharm; 2017 Aug; 528(1-2):485-497. PubMed ID: 28624661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
    Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
    Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
    Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
    Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and in vitro activity of dendrimer-streptokinase conjugates.
    Wang X; Inapagolla R; Kannan S; Lieh-Lai M; Kannan RM
    Bioconjug Chem; 2007; 18(3):791-9. PubMed ID: 17429940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
    Yue Y; Eun JS; Lee MK; Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer cells with biotin-dendrimer conjugates.
    Yang W; Cheng Y; Xu T; Wang X; Wen LP
    Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAMAM dendrimers for the delivery of the antibacterial Triclosan.
    Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
    Madaan K; Lather V; Pandita D
    Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
    Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
    Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
    J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.
    Teow HM; Zhou Z; Najlah M; Yusof SR; Abbott NJ; D'Emanuele A
    Int J Pharm; 2013 Jan; 441(1-2):701-11. PubMed ID: 23089576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.